Amble vs AltRx Tirzepatide: Flat-Rate Plans and Costs Compared

Last reviewed: September 5, 2026 Last updated: September 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Amble publishes transparent, ongoing month-to-month tirzepatide pricing: $289/month for starter doses (2.5–5 mg) and $329/month for higher doses (7.5–15 mg), captured September 4, 2026. AltRx advertises promotional tirzepatide pricing—$149/month month-to-month down to a $125/month equivalent on a 12-month prepaid plan—but the promotion ends September 5, 2026, and no standard or refill pricing is documented in any available source. That missing standard rate is a material gap: if you begin treatment under the promotional window, you have no way to forecast what continuation will cost once the promotion expires. Additionally, AltRx advertises "cancel anytime," yet individual Trustpilot and Reddit reports captured September 4, 2026, allege annual prebilling despite selecting month-to-month at signup, creating a conflict readers should confirm at checkout. For month-to-month transparency and predictable long-term cost, Amble's documented pricing offers clearer ground; for the lowest short-term rate inside the promotional window, AltRx's $149/month promotional figure is lower, but that advantage disappears the moment standard pricing becomes relevant and remains unknown.

At-a-glance comparison: Amble vs AltRx tirzepatide

All prices verified September 4, 2026. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Normalized pricing: like-for-like, 12-month cost

Month-to-month tirzepatide (our calculation)

• Amble low-dose (2.5–5 mg): $289/month × 12 = $3,468/year
• Amble high-dose (7.5–15 mg): $329/month × 12 = $3,948/year
• AltRx 1-month promotional: $149/month × 12 = $1,788/year (promotion ends September 5, 2026; standard rate unknown)

On a strictly promotional month-to-month basis, AltRx's $149/month limited-time rate (ending September 5, 2026) saves $1,680/year against Amble's low-dose tier and $2,160/year against Amble's high-dose tier. That advantage holds only while the promotion runs and only if no standard rate replaces it; the moment promotional pricing expires, the comparison loses its foundation.

Prepaid options (our calculation)

Amble does not document multi-month prepaid plans. AltRx offers 3-month, 6-month, and 12-month promotional prepaid tiers, all ending September 5, 2026:

• AltRx 3-month prepaid promotional: $432 upfront × 4 cycles/year = $1,728/year ($144/month prepaid equivalent)
• AltRx 6-month prepaid promotional: $780 upfront × 2 cycles/year = $1,560/year ($130/month prepaid equivalent)
• AltRx 12-month prepaid promotional: $1,500 upfront ($125/month prepaid equivalent)

The 12-month prepaid promotional rate yields the lowest per-month equivalent, but it requires $1,500 upfront and locks you into a full year with no documented refund or pro-rata cancellation terms. If your dose escalates, if side effects require a pause, or if the compound shortage ends and branded drugs become accessible, that prepayment carries risk the evidence does not resolve.

Decision factors: strengths and gaps

Amble strengths

• Ongoing published pricing: $289/month and $329/month rates are documented, not labeled promotional, and carry no expiration date—critical for forecasting long-term cost.
• Dose-tier structure: Lower starter doses cost $40/month less than higher doses, potentially saving $480/year if you remain effective at 2.5–5 mg.
• Transparent inclusions: All-inclusive pricing with no separate membership, shipping, or service fees documented.

Amble gaps

• Evidence source: Pricing documented via FAQ hosted on Canva; no direct checkout verification is captured in the evidence.
• No prepaid discount: No multi-month or annual prepay option is documented, so readers seeking upfront-commitment savings have no Amble path.
• Cancellation terms: Refund and cancellation policies are not documented in available sources.

AltRx strengths

• Lowest promotional rate: $149/month month-to-month (through September 5, 2026) undercuts Amble by $140–$180/month during the promotional window.
• Prepaid promotional tiers: 3-month, 6-month, and 12-month promotional prepaid options lower the effective monthly rate to $125/month at the 12-month level.
• Flat-dose promotional pricing: All doses carry the same promotional rate, eliminating dose-tier increases during dose escalation.

AltRx gaps

• No standard pricing documented: The promotional grid ends September 5, 2026, and no source documents what rate applies afterward—monthly subscribers starting on September 4 have no visibility into October's cost.
• Billing-conflict reports: AltRx advertises "cancel anytime," but individual Trustpilot and Reddit reports captured September 4, 2026, allege annual prebilling despite selecting month-to-month at checkout. The evidence documents the conflict but does not resolve it; readers must confirm billing terms before committing.
• Prepaid-refund terms unknown: Prepaid tiers lock in $432–$1,500 upfront with no documented pro-rata refund or cancellation policy if treatment becomes unsuitable.

Choose Amble if…

You want documented ongoing pricing with no promotional expiration and you value the ability to forecast 12-month cost at signup. Amble's $289/month (starter) and $329/month (higher-dose) rates provide that transparency. If you expect to remain effective at lower doses, the two-tier structure saves $480/year relative to the high-dose tier. Amble suits month-to-month subscribers who prioritize cost predictability over the lowest possible introductory rate.

Choose AltRx if…

You can begin treatment before September 5, 2026, you accept the risk that standard post-promotion pricing is unknown, and the promotional $149/month month-to-month rate (or $125/month prepaid equivalent) justifies that uncertainty. If you intend a short trial—one to three months—and plan to reassess before any standard rate takes effect, AltRx's promotional window offers the lowest documented entry cost. Confirm billing terms at checkout: the "cancel anytime" claim conflicts with individual reports of annual prebilling captured September 4, 2026, and resolving that conflict is essential before purchase.

Where PlexusDx fits

PlexusDx tirzepatide injection is $289/month month-to-month, $269/month on a 3-month plan (our calculation: $807 every three months), and $249/month on a 6-month plan (our calculation: $1,494 every six months). Over 12 months, the month-to-month plan costs $3,468 (our calculation), matching Amble's low-dose tier and exceeding AltRx's promotional rates. The 6-month plan brings the annual cost to $2,988 (our calculation), still above AltRx's promotional 12-month prepaid $1,500 but below Amble's high-dose tier.

PlexusDx pricing is ongoing and non-promotional—the rates documented today apply next month and next quarter, with no expiration date and no undisclosed standard tier. If you value that transparency and prefer a provider whose review data is public (PlexusDx holds a 4.2-star rating on Trustpilot, with 76% of reviews at five stars and 81% at four stars or higher, captured September 4, 2026), PlexusDx offers a middle-cost, high-transparency option. All-inclusive pricing covers your provider visit, prescription, medication, and shipping; no membership fee, no hidden charges.

Methodology and freshness

All Amble pricing was captured September 4, 2026, from the provider's FAQ hosted on Canva (https://amblefaq-glp1support.my.canva.site/). All AltRx promotional pricing was captured September 4, 2026, from the provider's promotional landing page (https://www.altrx.com/glp1/offer-v9-fl) and verified through intake (no payment submitted). The AltRx promotional grid states the promotion ends September 5, 2026. Trustpilot and Reddit reports alleging annual prebilling were captured September 4, 2026. PlexusDx Trustpilot rating was captured September 4, 2026.

Twelve-month cost calculations are ours, derived by multiplying the documented monthly rate by 12 or summing the documented prepaid cycles required to cover 12 months. Prepaid per-month equivalents (e.g., "$125/month prepaid equivalent") are our calculation, derived by dividing the upfront prepaid total by the number of months covered, and are labeled as such. No discount arithmetic was applied; all published figures reflect prices actually observed in the sources on the capture date.

No eligibility, medication type, dose, results, or side-effect outcomes are guaranteed. A licensed clinician reviews every intake and determines whether a prescription is appropriate for the individual patient.

Frequently Asked Questions

Does AltRx's promotional pricing apply to refills after September 5, 2026?

The available evidence does not document standard or refill pricing beyond the promotional window ending September 5, 2026. If you start treatment on September 4 under the $149/month promotional rate, confirm with AltRx what rate applies to your October refill before committing.

Why does Amble charge more for higher tirzepatide doses?

Amble uses a two-tier dose structure: $289/month covers 2.5–5 mg, and $329/month covers 7.5–15 mg. The $40/month difference likely reflects higher active-ingredient cost at higher doses. If you remain effective at a starter dose, you pay the lower tier; if you escalate, the higher tier applies.

Are AltRx's "cancel anytime" claims reliable given the prebilling reports?

AltRx advertises "cancel anytime" monthly billing, but individual Trustpilot and Reddit reports captured September 4, 2026, allege full annual prebilling despite selecting month-to-month at signup. The evidence documents the conflict but cannot resolve it. Confirm billing terms and any auto-renewal or prepayment clauses at checkout before purchase.

Which provider offers the lowest 12-month tirzepatide cost if I start today?

Inside AltRx's promotional window (ending September 5, 2026), the 12-month prepaid promotional plan at $1,500 upfront yields the lowest documented 12-month cost. Once the promotion ends and if standard pricing remains unknown, Amble's $289/month low-dose tier ($3,468/year, our calculation) becomes the lowest verifiable ongoing rate among the two providers compared.

Does PlexusDx tirzepatide pricing include provider visits and shipping?

Yes. PlexusDx tirzepatide injection at $289/month month-to-month (or $269/$249 per month on 3-month/6-month plans) is all-inclusive: online provider visit, prescription, compounded medication, and shipping are covered, with no separate membership fee or hidden charges.

Sources

• Amble FAQ (https://amblefaq-glp1support.my.canva.site/), accessed September 4, 2026
• AltRx promotional landing page (https://www.altrx.com/glp1/offer-v9-fl), accessed September 4, 2026
• AltRx intake verification (no payment submitted), captured September 4, 2026
• Trustpilot reports (Amble, AltRx), captured September 4, 2026
• Reddit discussions (AltRx billing), captured September 4, 2026
• PlexusDx Trustpilot profile, captured September 4, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.